Market open
OptimizeRx/$OPRX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About OptimizeRx
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Ticker
$OPRX
Sector
Trading on
Industry
Health Care Technology
Headquarters
Employees
136
Website
OptimizeRx Metrics
BasicAdvanced
$115M
Market cap
-
P/E ratio
-$1.02
EPS
1.26
Beta
-
Dividend rate
Price and volume
Market cap
$115M
Beta
1.26
52-week high
$16.65
52-week low
$5.04
Average daily volume
146K
Financial strength
Current ratio
3.074
Quick ratio
2.763
Long term debt to equity
26.911
Total debt to equity
29.819
Interest coverage (TTM)
-2.22%
Management effectiveness
Return on assets (TTM)
-4.27%
Return on equity (TTM)
-15.18%
Valuation
Price to revenue (TTM)
1.335
Price to book
0.95
Price to tangible book (TTM)
-23.86
Price to free cash flow (TTM)
-66.589
Growth
Revenue change (TTM)
35.15%
Earnings per share change (TTM)
22.55%
3-year revenue growth (CAGR)
17.11%
3-year earnings per share growth (CAGR)
189.92%
What the Analysts think about OptimizeRx
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for OptimizeRx stock.
OptimizeRx Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
OptimizeRx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
OptimizeRx News
AllArticlesVideos
OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET
GlobeNewsWire·1 week ago
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
GlobeNewsWire·2 months ago
OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for OptimizeRx stock?
OptimizeRx (OPRX) has a market cap of $115M as of November 08, 2024.
What is the P/E ratio for OptimizeRx stock?
The price to earnings (P/E) ratio for OptimizeRx (OPRX) stock is 0 as of November 08, 2024.
Does OptimizeRx stock pay dividends?
No, OptimizeRx (OPRX) stock does not pay dividends to its shareholders as of November 08, 2024.
When is the next OptimizeRx dividend payment date?
OptimizeRx (OPRX) stock does not pay dividends to its shareholders.
What is the beta indicator for OptimizeRx?
OptimizeRx (OPRX) has a beta rating of 1.26. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.